Carfilzomib
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB08889 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 10 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | CMM7 | KG + DL |
| 2 | pediatric leptomeningeal melanoma | KG + DL |
| 3 | epithelioid cell uveal melanoma | KG + DL |
| 4 | vulvar melanoma (disease) | KG + DL |
| 5 | melanoma | KG + DL |
| 6 | indolent plasma cell myeloma | KG + DL |
| 7 | intellectual disability, autosomal dominant 55, with seizures | KG + DL |
| 8 | myeloid leukemia | KG + DL |
| 9 | neutrophil immunodeficiency syndrome | KG + DL |
| 10 | central nervous system melanocytic neoplasm | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.